Rheumatoid Arthritis Refractory to DMARDs: A Case Study
Journal: Virology & Immunology Journal (Vol.2, No. 5)Publication Date: 2018-04-05
Authors : Sakhawat F; Sadeeqa S;
Page : 1-4
Keywords : Rheumatoid arthritis; Unfavorable outcomes; Refractory patients; DMARDs; Biologics;
Abstract
In past few years there has been an enthusiastic progress in the field of rheumatoid arthritis pharmacotherapy but the presence of prognostic factors associated with unfavorable outcomes and the inappropriate and/or delayed initiation of DMARDsmay diminish the likelihood of achieving remission and/or increase the probability of refractoriness to treatment.
Other Latest Articles
- Diabetes Mellitus: A Case Study
- Effect of Two Teaching Methods on Learning Outcomes Regarding Prevention of Cervical Cancer among Married Women in Rural Areas of Kannur District, Kerala-A Pilot Study
- An Observational Study of Obese Pregnancy
- Bioaccumulation of Some Metals in Different Organs of Frozen Spotted Seabass
- Emerging Viral Infectious Diseases-Peril to Human Health
Last modified: 2018-05-26 19:21:50